Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Peri-implantitis by Air-polishing Abrasives and Antiseptics Solutions
NCT07500844Completed
- Sponsor
- Research Centre for Medical Genetics
- Start
- Feb 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in peri-implantitis comparing Miramistin + Sodium Bicarbonate, Chlorhexidine + Erythritol and Octenisept + Glycine (3 arms). Primary endpoints: Probing Depth at 2.5 months and Bleeding on Probing at 2.5 months. Started Feb 2023; status: completed.
02
Drugs
miramistinchlorhexidineoctenidine dihydrochloride + phenoxyethanol
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT07500844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07500844.